InflaRx is a clinical-stage biopharmaceutical company based in Jena, Germany, that focuses on developing innovative therapeutics for acute and chronic inflammation. The company leverages its proprietary anti-C5a/C5aR technology to create potent inhibitors targeting the complement activation factor C5a and its receptor C5aR, which are implicated in various autoimmune and inflammatory diseases. InflaRx's lead product candidate, vilobelimab, is a novel monoclonal antibody administered intravenously that selectively binds to free C5a. It has shown promising disease-modifying activity and tolerability across multiple clinical settings. Founded in December 2017, InflaRx aims to translate scientific discoveries into effective treatments for patients suffering from inflammatory conditions.
InflaRx
Seed Round in 2008
InflaRx is a clinical-stage biopharmaceutical company based in Jena, Germany, that focuses on developing innovative therapeutics for acute and chronic inflammation. The company leverages its proprietary anti-C5a/C5aR technology to create potent inhibitors targeting the complement activation factor C5a and its receptor C5aR, which are implicated in various autoimmune and inflammatory diseases. InflaRx's lead product candidate, vilobelimab, is a novel monoclonal antibody administered intravenously that selectively binds to free C5a. It has shown promising disease-modifying activity and tolerability across multiple clinical settings. Founded in December 2017, InflaRx aims to translate scientific discoveries into effective treatments for patients suffering from inflammatory conditions.
Selfrag
Funding Round in 2007
Selfrag AG is a Swiss company that specializes in the development and marketing of high voltage electric pulse generators and electric pulse disaggregation (EPD) systems. Founded in 2007, the company focuses on selective fragmentation of solid materials, providing innovative alternatives to conventional crushing and grinding techniques. Its product lineup includes laboratory systems for selective fragmentation, rod crushers for the solar and semiconductor industries, and modular equipment for transporting and fragmenting bulky materials like rock and concrete. Selfrag’s technologies aim to enhance the value of extracted or recycled materials while significantly reducing energy consumption, thus promoting sustainable practices in mineral processing. The company serves various sectors, including geosciences, recycling, and mining, and has over 40 installations worldwide. In addition to its products, Selfrag offers laboratory testing, service packages, and training to support its clients in optimizing their operations.
SIRS-Lab
Venture Round in 2006
SIRS-Lab is a privately held diagnostic company developing unique and innovative products to identify and monitor life-threatening infections, one of the major causes of death in hospitals across the world. SIRS-Lab's vision is to support clinicians in their bedside decisions by providing them with fast and reliable high-performance point of care systems and thus, to improve therapeutic impact and reduce the mortality rate of patients. Founded in 2000 by S. Russwurm, K. Reinhart, E. Straube and H.-P. Saluz, SIRS-Lab employs today 45 people. The company currently commercializes VYOO, a molecular diagnostic test for the rapid identification of sepsis causing bacteria and fungi. Sepsis is one of the major causes of death in hospitals.
Dunes Technologies
Venture Round in 2006
Dunes Technologies specializes in developing and providing process automation and system management software tailored for virtual service and virtual desktop environments. Founded in 2000 and headquartered in Vaud, Switzerland, the company offers a comprehensive suite of cost-effective software tools aimed at efficiently managing virtual IT infrastructures. By leveraging automation, Dunes Technologies enhances IT operations performance and maximizes the benefits of virtualization. Their proactive service mediation platform is integral to the development of S-Ops products, which effectively manage application-based services throughout the entire operation life-cycle.
Dartfish
Venture Round in 2002
Dartfish SA specializes in developing video solutions that enable users to capture, analyze, and share video content effectively. Founded in 1998 and headquartered in Fribourg, Switzerland, the company offers a suite of applications and services, including myDartfish, a personal workspace for skill and game analysis, and myDartfish Express, which helps athletes identify areas for improvement. Their platform features myDartfish Smart Cloud for secure video storage and sharing, as well as ProSuite for automatic tracking of video annotations. Dartfish also provides tools for match analysis and data integration, along with Dartfish.tv, a platform for sharing video analysis. By serving diverse markets such as sports, education, healthcare, and industry, Dartfish makes video accessible to coaches, athletes, students, and organizations worldwide. The company operates additional offices across several countries, including the United States, Australia, and various locations in Europe and Asia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.